Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Aml M. Elgaml"'
Autor:
Wasil Jastaniah, Naglla Elimam, Khalid Abdalla, Aeshah A. AlAzmi, Aml M. Elgaml, Ahmad Alkassar, Mustafa Daghistani, Sami Felimban
Publikováno v:
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-15 (2018)
Abstract Background Refinement of risk-based treatment stratification by minimal residual disease (MRD) at different time points has improved outcomes of childhood acute lymphoblastic leukemia (ALL). In this prospective study we evaluated effects of
Externí odkaz:
https://doaj.org/article/5360adfac9934965b4bd6265988d5745
Autor:
Sami Felimban, Aeshah AlAzmi, Mustafa Daghistani, Ahmad Alkassar, Naglla Elimam, Wasil Jastaniah, Aml M. Elgaml, Khalid Abdalla
Publikováno v:
Experimental Hematology & Oncology
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-15 (2018)
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-15 (2018)
Background Refinement of risk-based treatment stratification by minimal residual disease (MRD) at different time points has improved outcomes of childhood acute lymphoblastic leukemia (ALL). In this prospective study we evaluated effects of such stra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4928d61c0baabb662d70b0129696dfb0
https://doi.org/10.1186/s40164-018-0121-x
https://doi.org/10.1186/s40164-018-0121-x